NEW YORK – Australian biopharmaceutical firm Beroni said on Monday that it has received CE marking for its SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method).
The colloidal gold solid-phase immunochromatography-based test kit is used to detect antigens against SARS-CoV-2 in nasopharyngeal swab samples, according to Beroni. Results are available within 10 minutes.
"People may never know they had COVID-19 with mild or even no symptoms," Beroni Chairman and CEO Jacky Zhang said in a statement. "But Beroni's SARS-CoV-2 Antigen Test Kit (Colloidal Gold Method) can let testers know whether they have the antigen … [which] can help them prepare for vaccination."
In April, Beroni received CE certification for its SARS-CoV-2 IgG/IgM Antibody Detection Kit, which the company has begun exporting to the UK, Japan, and other nations.